Delivery Order SPE2DB25D3504-SPE2DB25FVUML
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $12,853.61 delivery order contract to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This firm fixed price delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-set-aside competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $30,571.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on May 14, 2025, with completion targeted for May 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a $16,400.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This non-set-aside contract was competitively awarded on May 13, 2025, with an ultimate completion date of May 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,575.97 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections (2.24 mL units). This firm fixed-price contract, awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, was competitively awarded with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a FDA-approved medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,343.69 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken,...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,537.36 to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on September 10, 2025, with completion scheduled for September 11, 2025. The contract utilized firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVUMLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,288.59 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 29, 2025, issued on April 28, 2025. AmerisourceBergen will perform and deliver from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that has demonstrated extensive capability in fulfilling military and federal healthcare pharmaceutical requirements through competitive procurement. The parent IDC with DLA enables the company to supply a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for Forteo, a bone-building medication used in osteoporosis treatment, exemplifies the company's role in providing specialized pharmaceutical commodities across multiple therapeutic domains to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 4/28/25 |